Icariin stimulates osteogenic differentiation and suppresses adipogenic differentiation of rBMSCs via estrogen receptor signaling

Li,Xiaoyun; Peng,Bojia; Pan,Yanbin; Wang,Panpan; Sun,Kehuan; Lei,Xiaotong; Ou,Ling; Wu,Zhidi; Liu,Xiaoguang; Wang,Haixia; He,Haibin; Mo,Shu; Tian,Ya; Peng,Xunqian; Zhu,Xiaofeng; Zhang,Ronghua; Yang,Li

doi:10.3892/mmr.2018.9325

Icariin stimulates osteogenic differentiation and suppresses adipogenic differentiation of rBMSCs via estrogen receptor signaling

Authors:
- Xiaoyun Li
- Bojia Peng
- Yanbin Pan
- Panpan Wang
- Kehuan Sun
- Xiaotong Lei
- Ling Ou
- Zhidi Wu
- Xiaoguang Liu
- Haixia Wang
- Haibin He
- Shu Mo
- Ya Tian
- Xunqian Peng
- Xiaofeng Zhu
- Ronghua Zhang
- Li Yang
View Affiliations

Affiliations: Department of Traditional Chinese Pharmacology, College of Pharmacy, Jinan University, Guangzhou, Guangdong 510632, P.R. China, College of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong 510632, P.R. China, Department of The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong 510630, P.R. China
Published online on: July 26, 2018 https://doi.org/10.3892/mmr.2018.9325
Pages: 3483-3489

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Icariin (ICA) is a major active ingredient in Herba epimedii, which is commonly used as a Chinese herbal medicine for the treatment of osteoporosis. Previous studies have revealed that ICA exerted a protective effect against bone loss and increased bone regeneration; however, the association between ICA and estrogen receptor (ER) signaling remains unclear. The aim of the present study was to determine the effect of ICA on rat bone marrow stromal cells (rBMSCs). Cell Counting Kit‑8 assays were conducted to measure proliferation, alkaline phosphatase (ALP) activity was evaluated to assess osteoblast differentiation, and reverse transcription‑quantitative polymerase chain reaction as well as western blotting were performed to detect the expression of cellular and molecular markers of osteogenic or adipogenic differentiation. The results demonstrated that treatment of rBMSCs with 10‑6 M ICA stimulated rBMSC proliferation and ALP activity. Furthermore, ICA treatment increased the expression of the osteogenic markers runt‑related transcription factor 2, collagen type 1 and bone morphogenetic Protein 2; however, it also decreased the expression of the adipogenic differentiation markers peroxisome proliferator‑activated receptor gamma and CCAAT/enhancer‑binding protein α. Treatment of rBMSCs with ICI182780, an ER antagonist, blocked the effects of ICA. Taken together, these findings indicated that ICA may stimulate osteoblast differentiation and inhibit adipogenic differentiation via the activation of the ER signaling pathway. Therefore, ICA has the potential to serve as a therapeutic alternative for the prevention and treatment of osteoporosis.

View Figures

View References

1	Berendsen AD and Olsen BR: Osteoblast-adipocyte lineage plasticity in tissue development, maintenance and pathology. Cell Mol Life Sci. 71:493–497. 2014. View Article : Google Scholar : PubMed/NCBI
2	Devlin MJ and Rosen CJ: The bone-fat interface: Basic and clinical implications of marrow adiposity. Lancet Diabetes Endocrinol. 3:141–147. 2015. View Article : Google Scholar : PubMed/NCBI
3	Eriksen EF, Díez-Pérez A and Boonen S: Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: A systematic review. Bone. 58:126–135. 2014. View Article : Google Scholar : PubMed/NCBI
4	Nguyen PL, Alibhai SM, Basaria S, D'Amico AV, Kantoff PW, Keating NL, Penson DF, Rosario DJ, Tombal B and Smith MR: Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol. 67:825–836. 2015. View Article : Google Scholar : PubMed/NCBI
5	Francis MD and Valent DJ: Historical perspectives on the clinical development of bisphosphonates in the treatment of bone diseases. J Musculoskelet Neuronal Interact. 7:2–8. 2007.PubMed/NCBI
6	Gao B, Huang Q, Lin YS, Wei BY, Guo YS, Sun Z, Wang L, Fan J, Zhang HY, Han YH, et al: Dose-dependent effect of estrogen suppresses the osteo-adipogenic transdifferentiation of osteoblasts via canonical Wnt signaling pathway. PLoS One. 9:e991372014. View Article : Google Scholar : PubMed/NCBI
7	Zhang YL, Jiang JJ, Shen H, Chai Y, Wei X and Xie YM: Total flavonoids from Rhizoma Drynariae (Gusuibu) for treating osteoporotic fractures: Implication in clinical practice. Drug Design Dev Ther. 11:1881–1890. 2017. View Article : Google Scholar
8	Hu J, Mao Z, He S, Zhan Y, Ning R, Liu W, Yan B and Yang J: Icariin protects against glucocorticoid induced osteoporosis, increases the expression of the bone enhancer DEC1 and modulates the PI3K/Akt/GSK β/β-catenin integrated signaling pathway. Biochem Pharmacol. 136:109–121. 2017. View Article : Google Scholar : PubMed/NCBI
9	Wu Y, Cao L, Xia L, Wu Q, Wang J, Wang X, Xu L, Zhou Y, Xu Y and Jiang X: Evaluation of osteogenesis and angiogenesis of icariin in local controlled release and systemic delivery for calvarial defect in ovariectomized rats. Sci Rep. 7:50772017. View Article : Google Scholar : PubMed/NCBI
10	Fu S, Yang L, Hong H and Zhang R: Wnt/β-catenin signaling is involved in the Icariin induced proliferation of bone marrow mesenchymal stem cells. J Tradit Chin Med. 36:360–368. 2016.(In Chinese). View Article : Google Scholar : PubMed/NCBI
11	Song L, Zhao J, Zhang X, Li H and Zhou Y: Icariin induces osteoblast proliferation, differentiation and mineralization through estrogen receptor-mediated ERK and JNK signal activation. Eur J Pharmacol. 714:15–22. 2013. View Article : Google Scholar : PubMed/NCBI
12	Niada S, Giannasi C, Ferreira LM, Milani A, Arrigoni E and Brini AT: 17β-estradiol differently affects osteogenic differentiation of mesenchymal stem/stromal cells from adipose tissue and bone marrow. Differentiation. 92:291–297. 2016. View Article : Google Scholar : PubMed/NCBI
13	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
14	Martin A, Yu J, Xiong J, Khalid AB, Katzenellenbogen B, Kim SH, Katzenellenbogen JA, Malaivijitnond S, Gabet Y, Krum SA and Frenkel B: Estrogens and androgens inhibit association of RANKL with the pre-osteoblast membrane through post-translational mechanisms. J Cell Physiol. 232:3798–3807. 2017. View Article : Google Scholar : PubMed/NCBI
15	Bord S, Horner A, Beavan S and Juliet C: Estrogen receptors alpha and beta are differentially expressed in developing human bone. J Clin Endocrinol Metab. 86:2309–2314. 2001. View Article : Google Scholar : PubMed/NCBI
16	Li X, Song QS, Wang JY, Leng HJ, Chen ZQ, Liu ZJ, Dang GT and Song CL: Simvastatin induces estrogen receptor-alpha expression in bone, restores bone loss, and decreases ERα expression and uterine wet weight in ovariectomized rats. J Bone Miner Metab. 29:396–403. 2011. View Article : Google Scholar : PubMed/NCBI
17	An X, Ma K, Zhang Z, Zhao T, Zhang X, Tang B and Li Z: miR-17, miR-21, and miR-143 enhance adipogenic differentiation from porcine bone marrow-derived mesenchymal stem cells. DNA Cell Biol. 35:410–416. 2016. View Article : Google Scholar : PubMed/NCBI
18	Wei Q, Zhang J, Hong G, Chen Z, Deng W, He W and Chen MH: Icariin promotes osteogenic differentiation of rat bone marrow stromal cells by activating the ERα-Wnt/β-catenin signaling pathway. Biomed Pharmacother. 84:931–939. 2016. View Article : Google Scholar : PubMed/NCBI
19	Stucki U, Schmid J, Hämmerle CF and Lang NP: Temporal and local appearance of alkaline phosphatase activity in early stages of guided bone regeneration. A descriptive histochemical study in humans. Clin Oral Implants Res. 12:121–127. 2001. View Article : Google Scholar : PubMed/NCBI
20	Wei QS, He MC, Chen MH, Chen ZQ, Yang F, Wang HB, Zhang J and He W: Icariin stimulates osteogenic differentiation of rat bone marrow stromal stem cells by increasing TAZ expression. Biomed Pharmacother. 91:581–589. 2017. View Article : Google Scholar : PubMed/NCBI
21	Liu H, Xiong Y, Zhu X, Gao H, Yin S, Wang J, Chen G, Wang C, Xiang L, Wang P, et al: Icariin improves osteoporosis, inhibits the expression of PPARγ, C/EBPα, FABP4 mRNA, N1ICD and jagged1 proteins, and increases Notch2 mRNA in ovariectomized rats. Exp Ther Med. 13:1360–1368. 2017. View Article : Google Scholar : PubMed/NCBI
22	Wang H, Jiang Z, Zhang J, Xie Z, Wang Y and Yang G: Enhanced osteogenic differentiation of rat bone marrow mesenchymal stem cells on titanium substrates by inhibiting Notch3. Arch Oral Biol. 80:34–40. 2017. View Article : Google Scholar : PubMed/NCBI
23	Kim J, Lee HW, Rhee DK, Paton JC and Pyo S: Pneumolysin-induced autophagy contributes to inhibition of osteoblast differentiation through downregulation of Sp1 in human osteosarcoma cells. Biochim Biophys Acta. 1861:2663–2673. 2017. View Article : Google Scholar : PubMed/NCBI
24	Huang W, Rudkin GH, Carlsen B, Ishida K, Ghasri P, Anvar B, Yamaguchi DT and Miller TA: Overexpression of BMP-2 modulates morphology, growth, and gene expression in osteoblastic cells. Exp Cell Res. 274:226–234. 2002. View Article : Google Scholar : PubMed/NCBI
25	Li Y, Rong Y, Bao L, Nie B, Ren G, Zheng C, Amin R, Arnold RD, Jeganathan RB and Huggins KW: Suppression of adipocyte differentiation and lipid accumulation by stearidonic acid (SDA) in 3T3-L1 cells. Lipids Health Dis. 16:1812017. View Article : Google Scholar : PubMed/NCBI
26	Wu Y, Xia L, Zhou Y, Xu Y and Jiang X: Icariin induces osteogenic differentiation of bone mesenchymal stem cells in a MAPK-dependent manner. Cell Prolif. 48:375–384. 2015. View Article : Google Scholar : PubMed/NCBI
27	Tao ZR, Liu J, Jiang YM, Gong L and Yang B: Synthesis of prenylated flavonols and their potents as estrogen receptor modulator. Sci Rep. 7:124452017. View Article : Google Scholar : PubMed/NCBI